The government and ruling People Power Party are pressing harder than expected to increase the number of medical doctors. PPP, in particular, has recently raised its pressure, saying that the doctor shortage results from physicians’ “collective selfishness.”“The imbalance between the supply and dema
Huonslab, a subsidiary of Huons Global, has taken a step closer to developing the first locally developed human hyaluronidase enzyme product.Hyaluronic acid is used as a drug-spreading agent that directly decomposes hyaluronic acid present in the human body subcutaneously to remove pain and swelling
Ipsen Korea is focusing on renewing the risk-sharing agreement (RSA) for its targeted chemotherapy Cabometyx (cabozantinib) ahead of expanding its indication to treating kidney cancer.On Feb. 1, 2019, Cabometyx was registered to receive insurance benefits in treating progressive kidney cell cancer p
When treating lung cancer, checking whether the patient has a genetic mutation and what type of mutation is getting more important, experts said. Among non-small cell lung cancer (NSCLC) cases, which accounts for 85 percent of all lung cancer, only 21.7 percent of the patients have no active genetic
An appellate court has overruled the lowest court's decision and ruled in favor of a same-sex couple that filed an administrative lawsuit against the National Health Insurance Service (NHIS) asking for recognition of their qualifications for the health insurance dependent policy.The ruling overturne
KAIST said that Professor Park Hee-Sung's team from the Department of Chemistry developed a new drug discovery platform technology based on cyclic peptides that can be designed according to various biomarkers.Cyclic peptides have received a lot of attention due to their low toxicity and excellent ph
A joint team of researchers said on Tuesday that they developed a liquid biopsy technology that can diagnose biliary tract cancer early using extracellular vesicles, with an accuracy 1.3 times higher than conventional methods.Currently, the diagnosis rate of a standard liquid biopsy CA19-9 test stan
Daiichi Sankyo Korea said Monday that it has appointed Kim Jeong-tae, vice president of Daiichi Sankyo Korea, as its new president, effective on April 1.Kim's appointment follows the outgoing President Kim Dae-jung's decision to retire on March 31.Kim graduated from the Sungkyunkwan University Colle
Researchers in Korea have published a study demonstrating that the rate of frailty was 2.68 times higher in those who experience difficulty chewing food, emphasizing the importance of dental health.Frailty refers to the condition whereby physical functions weaken more rapidly than normal aging, incr
When it comes to cancer, except for blood cancer, it is generally diagnosed by biopsy. However, there is a way to diagnose cancer without a biopsy. Radiopharmaceuticals are the answer.The frontrunner in the Korean radiopharmaceutical market is DuoChemBio. Although a latecomer, it covers a full range
Bridge Biotherapeutics has failed to confirm the efficacy of its ulcerative colitis treatment BBT-401-1S in multinational phase 2a clinical trials.The company announced the result of the BBT-401-1S phase 2a clinical trial in a public filing on Friday. It conducted the trial on 38 moderate to severe
GI Innovation, which was expected to record the largest initial public offering (IPO) among Korean biotech firms this year, suddenly postponed its market debut.The sudden postponement comes after the Financial Services Commission (FSC) requested corrections to the company’s securities report submitt
GC Biopharma said on Monday that its chickenpox vaccine, Barycela, has obtained prequalification (PQ) certification from the World Health Organization (WHO), following the same certification for its H1N1 pandemic and seasonal influenza vaccines.The system evaluates the quality, effectiveness, and sa
Novo Nordisk Korea’s top manager said the company will more than double the market share in domestic diabetes treatment, aiming to treat 550,000 patients in Korea by 2025. Korea has about 6 million diabetic patients, according to the Korean Diabetes Association.Novo Nordisk General Manager Sasha Sem
Though it is not just Korea feeling the sting of low investor sentiment in the bioindustry, it is clear that swift government intervention is crucial to help refuel investment in Korea’s bioindustry.The Korean government provides incentives such as tax support, eased rules in building R&D facilities
Ildong Pharmceutical’s independently developed targeted anticancer drug, Venadaparib (IDX-1197 in development name), has been used to treat patients in clinical fields, drawing the industry’s attention.The Ministry of Food and Drug Safety approved the drug’s use to treat two patients last Friday.It
Korea has the optimal situation to eradicate hepatitis C because accurate tests and highly safe and effective therapies are easily available, a hepatitis expert said.John Ward, a director at the Coalition for Global Hepatitis Elimination (CGHE), spoke with Korea Biomedical Review in an online interv
Artificial intelligence-based chest X-ray image reading assistance has demonstrated its effectiveness in real-world clinical settings. For example, the detection rate of lung nodules used in lung cancer diagnosis based on AI programs showed an improved detection rate.The research team led by Profess
Seegene, the Korean diagnostic kit maker, said its annual sales and operating profit fell drastically in 2022 due to the easing of the Covid-19 pandemic.According to the company's public filing on Friday, the company recorded sales and operating profit of 853.3 billion won ($657.1 million) and 195.9
Hanmi Pharm has unveiled a plan to develop belvarafenib as its new targeted chemotherapy with the pipeline name HM95573 Tab.In a briefing to Minister of Food and Drug Safety Oh Yu-kyoung at the company’s research center, Hanmi Vice President Suh Gwi-hyun said the company had selected belvarafenib, a